glp-1 colorectal cancer risk study november 2025 Glucagon-like peptide 1 receptor agonists and risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research glp-1 colorectal cancer risk study
Description
New research is taking a closer look at what can happen when people stop taking GLP-1 medications for a long period of time.
Protect muscle, boost energy, and make results last for life.
Mark: Amazon.sg: Books
I ordered GLP-1s from LifeRx, reviewed the service myself, and scored it 69/100
Study of nearly 8,000 patients finds that stopping semaglutide or tirzepatide leads to far less weight regain than clinical trials suggested.
